In vivo release of tissue-type plasminogen activator antigen from the human brachial artery

Thrombosis Research

Volumn 106, Issue 4-5, 2002, Pages 249-255

  Dovjak, Neda ^a   Blinc, Aleš ^a   Keber, Dušan ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Inst Hlth of the Rep of Slovenia   (Slovenia)

Author keywords

Artery; Release; t PA

Indexed keywords

ANTIGEN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTERY BLOOD FLOW; ARTERY ENDOTHELIUM; ARTERY OCCLUSION; ARTERY WALL; ARTICLE; BLOOD ANALYSIS; BRACHIAL ARTERY; CONTROLLED STUDY; ENZYME RELEASE; FOREARM; HUMAN; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SPHYGMOMANOMETER; ULTRASOUND; BIOLOGICAL MODEL; BLOOD; BLOOD FLOW VELOCITY; KINETICS; LIGATION; SECRETION;

ADULT; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CONSTRICTION; HUMANS; KINETICS; MALE; MODELS, CARDIOVASCULAR; SPHYGMOMANOMETERS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0037092638     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00132-9     Document Type: Article

References (34)

1. Collen D. The plasminogen (fibrinolytic system). Thromb. Haemost. 82:1999;259-270.
2. Reidy M.A., Irvin C. Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries. Circ. Res. 78:1996;405-414.
3. Marti H.H., Risau W. Angiogenesis in ischemic disease. Thromb. Haemost. 82(Suppl. 1):1999;44-52.
4. Griffioen A.W., Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52:2000;237-268.
5. Isner J.M. Angiogenesis: a "breakthrough" technology in cardiovascular medicine. J. Invas. Cardiol. 12(Suppl. A):2000;14A-17A.
6. Stein C.M., Brown N., Vaughan D.E., Lang C.C., Wood A.J. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J. Am. Coll. Cardiol. 32:1998;117-122.
7. Newby D.E., McLeod A.L., Uren N.G., Flint L., Ludlam C.A., Webb D.J.et al. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation. 103:2001;1936-1941.
8. Keber D. Mechanism of tissue plasminogen activator release during venous occlusion. Fibrinolysis. 2(Suppl. 2):1998;96-103.
9. Keber D., Stegnar M., Kluft C. Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion. Thromb. Haemost. 63:1990;72-75.
10. Keber D., Blinc A., Fettich J. Increase of tissue plasminogen activator in limbs during venous occlusion: a simple haemodynamic model. Thromb. Haemost. 64:1990;433-437.
11. Jern C., Selin L., Tengborn L., Jern S. Sympathoadrenal activation and muscarinic receptor stimulation stimulate acute release of tissue plasminogen activator but not von Wilenbrand factor across the human forearm. Thromb. Haemost. 78:1997;887-891.
12. Jern C., Seeman-Lodding H., Biber B., Winsö O., Jern S. An experimental multiple-organ model for the study of regional net release/uptake rates of tissue-type plasminogen activator in the intact pig. Thromb. Haemost. 78:1997;1150-1156.
13. Speiser W., Anders E., Preissner K.T., Wagner O., Müller-Berghaus G. Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and human umbilical veins. Blood. 69:1987;964-967.
14. Larsson Å., Åstedt B. Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vascular wall. J. Clin. Pathol. 38:1985;140-145.
15. Gough S.C.L., Smyllie J., Sheldon T., Rice P.J., Grant P.J. The anatomical distribution of plasma fibrinolytic activity in man during cardiac catheterisation. Thromb. Haemost. 68:1992;442-447.
16. Hanss M., Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin and histamine. J. Lab. Clin. Med. 109:1987;97-104.
17. Jern C., Selin L., Jern S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb. Haemost. 72:1994;285-291.
18. Wall U., Jern C., Bergbrant A., Jern S. Enhanced levels of tissue-type plasminogen activator in borderline hypertension. Hypertension. 26:1995;796-800.
19. Wall U., Jern C., Jern S. High capacity for tissue type plasminogen activator release from vascular endothelium in vivo. J. Hypertens. 15:1997;1641-1647.
20. Jern S., Wall U., Bergbrant A., Selin-Sjogren L., Jern C. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension. Arterioscler. Thromb. Vasc. Biol. 17:1997;3376-3383.
21. Wall U., Jern S., Tengborn L., Jern C. Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. Blood. 91:1998;529-537.
22. Newby D.E., Wright R.A., Ludlam C.A., Fox K.A., Boon N.A., Webb D.J. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium. Thromb. Haemost. 78:1997;1242-1248.
23. Wilsdorf T., Gainer J.V., Murphey L.J., Vaughan D.E., Brown N.J. Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm. Hypertension. 37:2001;1136-1140.
24. Minai K., Matsumoto T., Horie H., Ohira N., Takashima H., Yokohama H.et al. Bradykinin stimulates the release rate of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors. J. Am. Coll. Cardiol. 37:2001;1565-1570.
25. Rånby M., Nguyen G., Scarabin P.Y., Samama M.M. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Thromb. Haemost. 61:1989;409-414.
26. Declerck P.J., Verstreken M., Collen D. Measurement of different forms of plasminogen activator inhibitor-1 (PAI-1) using various monoclonal antibody-based enzyme-linked immunosorbent assays. Fibrinolysis. 4(Suppl. 2):1990;132-133.
27. Stegnar M., Mavri A. Reproducibilty of fibrinolytic response to venous occlusion in healthy subjects. Thromb. Haemost. 73:1995;453-457.
28. Dawson D.L., Strandness D.E. Duplex scanning. Strandness D.E., van Breda A. Vascular disease - surgical and interventional therapy. 1994;157-199 Churchill Livingstone, New York.
29. Ogawa T., Lurie F., Kistner R.L., Eklof B., Tabrah F.L. Reproducibility of ultrasound scan in the assessment of volume flow in the veins of lower extremities. J. Vasc. Surg. 35:2002;527-531.
30. Van den Ejnden-Schrauwen Y., Kooistra T., De Vries R.E.M., Emeis J.J. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and rats in vivo: evidence for a dynamic storage pool. Blood. 85:1995;3510-3517.
31. Jern C., Ladenvall P., Wall U., Jern S. Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA. Arterioscler. Thromb. Vasc. Biol. 19:1999;454-459.
32. Chandler W.L., Levy W.C., Stratton J.R. The circulatory regulation of tPA and uPA secretion, clearance, and inhibition during exercise and during infusion of isoproterenol and phenylephrine. Circulation. 92:1995;2984-2994.
33. Witzleb E. Functions of the vascular system. Schmidt R.F., Thews G. Human physiology. 1983;397-455 Springer-Verlag, New York.
34. Chandler W.L., Loo S.C., Mornin D. Adrenergic stimulation of regional plasminogen activator release in rabbits. Thromb. Haemost. 68:1992;545-549.